Transient loss of HGV induced by interferon treatment does non modify the response of HCV in chronic hepatitis C.

被引:0
|
作者
Benetti, G
Ramella, G
Tagger, A
Ribero, ML
Merlini, R
Lazza, M
Fasola, M
Portera, G
机构
[1] Melegnano Hosp, Milan, Italy
[2] Univ Milan, Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1860
引用
收藏
页码:625A / 625A
页数:1
相关论文
共 50 条
  • [1] Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection.
    Benetti, GP
    Ramella, G
    Lazza, M
    Corbellini, A
    Vitaliani, G
    Fasola, M
    Portera, G
    Ribero, ML
    Tagger, A
    HEPATOLOGY, 1997, 26 (04) : 1410 - 1410
  • [2] Association between HCV genotype and response to interferon treatment in chronic hepatitis C.
    GarciaBengoechea, M
    Cilla, G
    Montalvo, I
    Setas, AG
    Lasa, IG
    PerezTrallero, E
    Arenas, JI
    GASTROENTEROLOGY, 1996, 110 (04) : A1193 - A1193
  • [3] Interferon therapy for serum HGV RNA positive chronic hepatitis C.
    Shibahara, N
    Moriyama, M
    Kasuya, A
    Matsumura, H
    Segawa, T
    Shimizu, T
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Abe, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1381 - A1381
  • [4] Hepatitis G virus (HGV) coinfection does not influence response to interferon in patients with chronic HCV infection.
    SedghiVaziri, A
    Nainan, OV
    McHutchison, JG
    Alter, MJ
    HEPATOLOGY, 1996, 24 (04) : 408 - 408
  • [5] Interferon/ribavirin treatment in interferon non-responders with chronic hepatitis C.
    Teuber, G
    Berg, T
    Leidig, L
    Hoffmann, RM
    Lafrenz, M
    Spengier, U
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [6] Effect of interferon treatment in HGV and HCV coinfected patients with chronic active hepatitis.
    Segawa, T
    Moriyama, M
    Miyauchi, I
    Matsumura, H
    Shimizu, T
    Kanda, K
    Shibahara, N
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Abe, K
    HEPATOLOGY, 1996, 24 (04) : 1799 - 1799
  • [7] Predictors of response to interferon in chronic hepatitis C.
    Mollison, L
    Totten, L
    Olynyk, J
    Greenfield, C
    Beaman, M
    HEPATOLOGY, 1998, 28 (04) : 710A - 710A
  • [8] Interferon, body mass index, and response to treatment in chronic hepatitis C.
    Oliver, DL
    Monson, P
    Pohl, A
    Campbell, D
    Hassanein, TI
    HEPATOLOGY, 2000, 32 (04) : 571A - 571A
  • [9] Changes of HGV RNA titer during and after interferon therapy in chronic hepatitis C.
    Segawa, T
    Moriyama, M
    Shibahara, N
    Kasuya, A
    Iwaguchi, K
    Ichijima, S
    Iwasaki, H
    Matsumura, H
    Shimizu, T
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Abe, K
    HEPATOLOGY, 1997, 26 (04) : 1884 - 1884
  • [10] Doses adjustment of interferon alpha according to the HCV-RNA response in chronic hepatitis C.
    Ouzan, D
    Baldini, E
    Khiri, H
    Brichetti, A
    Halfon, P
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A